tetano
Editor, Senior Moderator
Emerg Infect Dis
. 2022;28(13):255-261.
doi: 10.3201/eid2813.212352.
Infection Prevention and Control Initiatives to Prevent Healthcare-Associated Transmission of SARS-CoV-2, East Africa
Danica J Gomes, Carmen Hazim, Jacqueline Safstrom, Carolyn Herzig, Ulzii Luvsansharav, Cori Dennison, Yakob Ahmed, Evelyn Wesangula, Joseph Hokororo, Jackson Amone, Berhanu Tekle, George Owiso, Rita Mutayoba, Mohammed Lamorde, Evelyn Akello, Getachew Kassa, Beniam Feleke, Linus Ndegwa, Kokuhumbya Kazaura, Diriisa Musisi, Anand Date, Benjamin J Park, Elizabeth Bancroft
Abstract
The coronavirus disease pandemic has highlighted the need to establish and maintain strong infection prevention and control (IPC) practices, not only to prevent healthcare-associated transmission of SARS-CoV-2 to healthcare workers and patients but also to prevent disruptions of essential healthcare services. In East Africa, where basic IPC capacity in healthcare facilities is limited, the US Centers for Disease Control and Prevention (CDC) supported rapid IPC capacity building in healthcare facilities in 4 target countries: Tanzania, Ethiopia, Kenya, and Uganda. CDC supported IPC capacity-building initiatives at the healthcare facility and national levels according to each country's specific needs, priorities, available resources, and existing IPC capacity and systems. In addition, CDC established a multicountry learning network to strengthen hospital level IPC, with an emphasis on peer-to-peer learning. We present an overview of the key strategies used to strengthen IPC in these countries and lessons learned from implementation.
Keywords: COVID-19; East Africa; Ethiopia; Kenya; SARS-CoV-2; Tanzania; Uganda; capacity building; coronavirus disease; coronaviruses; essential healthcare services; healthcare facilities; healthcare workers; healthcare-associated transmission; infection prevention and control initiatives; low-income countries; middle-income countries; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
. 2022;28(13):255-261.
doi: 10.3201/eid2813.212352.
Infection Prevention and Control Initiatives to Prevent Healthcare-Associated Transmission of SARS-CoV-2, East Africa
Danica J Gomes, Carmen Hazim, Jacqueline Safstrom, Carolyn Herzig, Ulzii Luvsansharav, Cori Dennison, Yakob Ahmed, Evelyn Wesangula, Joseph Hokororo, Jackson Amone, Berhanu Tekle, George Owiso, Rita Mutayoba, Mohammed Lamorde, Evelyn Akello, Getachew Kassa, Beniam Feleke, Linus Ndegwa, Kokuhumbya Kazaura, Diriisa Musisi, Anand Date, Benjamin J Park, Elizabeth Bancroft
- PMID: 36502401
- DOI: 10.3201/eid2813.212352
Abstract
The coronavirus disease pandemic has highlighted the need to establish and maintain strong infection prevention and control (IPC) practices, not only to prevent healthcare-associated transmission of SARS-CoV-2 to healthcare workers and patients but also to prevent disruptions of essential healthcare services. In East Africa, where basic IPC capacity in healthcare facilities is limited, the US Centers for Disease Control and Prevention (CDC) supported rapid IPC capacity building in healthcare facilities in 4 target countries: Tanzania, Ethiopia, Kenya, and Uganda. CDC supported IPC capacity-building initiatives at the healthcare facility and national levels according to each country's specific needs, priorities, available resources, and existing IPC capacity and systems. In addition, CDC established a multicountry learning network to strengthen hospital level IPC, with an emphasis on peer-to-peer learning. We present an overview of the key strategies used to strengthen IPC in these countries and lessons learned from implementation.
Keywords: COVID-19; East Africa; Ethiopia; Kenya; SARS-CoV-2; Tanzania; Uganda; capacity building; coronavirus disease; coronaviruses; essential healthcare services; healthcare facilities; healthcare workers; healthcare-associated transmission; infection prevention and control initiatives; low-income countries; middle-income countries; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.